195 related articles for article (PubMed ID: 15827053)
1. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures.
Thorpe R; Swanson SJ
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv16-22. PubMed ID: 15827053
[TBL] [Abstract][Full Text] [Related]
2. What is antibody-mediated pure red cell aplasia (PRCA)?
Casadevall N
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv3-8. PubMed ID: 15827056
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera.
Hoesel W; Gross J; Moller R; Kanne B; Wessner A; Müller G; Müller A; Gromnica-Ihle E; Fromme M; Bischoff S; Haselbeck A
J Immunol Methods; 2004 Nov; 294(1-2):101-10. PubMed ID: 15604020
[TBL] [Abstract][Full Text] [Related]
4. Application of a bridging ELISA for detection of anti-erythropoietin binding antibodies and a cell-based bioassay for neutralizing antibodies in human sera.
Shin SK; Ha SK; Lee KW; Yoo TH; Yun SR; Yoon SH; Kim SJ; Lee SK; Heo TH
J Pharm Biomed Anal; 2010 Jun; 52(2):289-93. PubMed ID: 20133098
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks.
Macdougall IC
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv9-15. PubMed ID: 15827058
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options.
Rossert J; Macdougall I; Casadevall N
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv23-26. PubMed ID: 15827054
[TBL] [Abstract][Full Text] [Related]
7. [Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].
Janda K; Kraśniak A; Krzanowski M; Sułowicz W
Przegl Lek; 2010; 67(3):187-91. PubMed ID: 20687383
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA
Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586
[TBL] [Abstract][Full Text] [Related]
9. Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparison.
Barger TE; Kuck AJ; Chirmule N; Swanson SJ; Mytych DT
Nephrol Dial Transplant; 2012 Feb; 27(2):688-93. PubMed ID: 21602184
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated pure red cell aplasia (PRCA): ensuring future progress by collecting data from a registry.
Aljama P; Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; Martin de Francisco AL
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv27-30. PubMed ID: 15827055
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Carson KR; Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
[TBL] [Abstract][Full Text] [Related]
12. Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies.
Yang J; Joo KW; Kim YS; Ahn C; Han JS; Kim S; Lee JS
J Nephrol; 2005; 18(1):102-5. PubMed ID: 15772931
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing.
Mytych DT; Barger TE; King C; Grauer S; Haldankar R; Hsu E; Wu MM; Shiwalkar M; Sanchez S; Kuck A; Civoli F; Sun J; Swanson SJ
J Immunol Methods; 2012 Aug; 382(1-2):129-41. PubMed ID: 22634015
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
[TBL] [Abstract][Full Text] [Related]
15. Immunologic mechanisms of EPO-associated pure red cell aplasia.
Schellekens H
Best Pract Res Clin Haematol; 2005; 18(3):473-80. PubMed ID: 15792922
[TBL] [Abstract][Full Text] [Related]
16. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agents].
Rossert J; Casadevall N
Nephrol Ther; 2006 Sep; 2 Suppl 4():S283-6. PubMed ID: 17373271
[TBL] [Abstract][Full Text] [Related]
18. Pure red cell aplasia induced only by intravenous administration of recombinant human erythropoietin.
Shimizu H; Saitoh T; Ota F; Jimbo T; Tsukada Y; Murakami H; Nojima Y
Acta Haematol; 2011; 126(2):114-8. PubMed ID: 21654161
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge.
Smalling R; Foote M; Molineux G; Swanson SJ; Elliott S
Biotechnol Annu Rev; 2004; 10():237-50. PubMed ID: 15504708
[TBL] [Abstract][Full Text] [Related]
20. Development of a chemiluminescent imaging assay for the detection of anti-erythropoietin antibody in human sera.
Wang W; Lu Y; Zhang S; Wang S; Cao P; Tian Y; Zhang X
Luminescence; 2009; 24(1):55-61. PubMed ID: 18780331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
